Red Queen Therapeutics

$4.5M revenue • 25 employees • United States

Last Updated Mar 11, 2025

Company Overview

Company Name

Red Queen Therapeutics

Address

United States

Approx. Annual Revenue

$4.5M

Employees

25

Established

2021

About Red Queen Therapeutics

Red Queen Therapeutics is a clinical-stage company based in the United States, working to develop innovative antiviral therapies that block virus-cell fusion and halt disease progression. Their novel stapled lipopeptide platform technology offers key advantages, including a high barrier to resistance, room temperature stability, and versatile formulations for easy administration.

Business Profile

Read from the Red Queen Therapeutics website on Oct 11, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed)
8/10 · Clear and detailed description of science and platform; Current news and publications listed; Contact form provided
Footer copyright year
2026

Biotech & Life Sciences Companies near MA

Browse all Biotech & Life Sciences companies in Massachusetts →

Frequently Asked Questions about Red Queen Therapeutics

Categories

Technologies Used

Social Profiles

Key Decision Makers

Kristin Kenaston Head of Clinical Operations
LinkedIn